Sotera Health Company’s (NASDAQ:SHC) Q3 2026 sales top estimates, stock jumps 12.9%
Sotera Health (SHC) reported Q3 2026 revenue of $324.9M, beating estimates by 1.6%. Adjusted EPS was $0.29, an 8% beat. The company reconfirmed its full-year revenue and EPS guidance. Operating margin remained steady at 35.9%, while free cash flow margin improved to 17.8%.
How this was made

The 30-second read
Why it matters
The combination of Q3 beats and reconfirmed FY guidance is a near-term positive catalyst, likely prompting analysts to adjust models and traders to reprice near-term expectations.
Market read
A same-day earnings print with guidance reconfirmation and a double-digit stock move makes this actionable for short-term positioning and expectation-setting.
What to watch
Free cash flow margin improved year over year, but the article does not break down drivers (working capital vs. operations), which could affect sustainability of the cash-flow trend.
Background
The piece summarizes Sotera Health’s Q3 2026 results versus S&P analysts’ consensus and reiterates full-year guidance.
Ticker impact
Sotera Health reported Q3 2026 revenue and adjusted EPS above consensus, and reconfirmed full-year guidance while shares jumped 12.9%.
Likely upward bias as the market digests the beat and treats the reconfirmed FY guidance as a credibility signal.
The article provides specific Q3 beat figures and states management reconfirmed FY revenue and adjusted EPS guidance at the midpoint, aligning with the reported 12.9% jump.
Market effects
Supports sentiment for healthcare services providers with similar margin and cash-flow profiles, but no direct sector-wide catalyst is provided.
Primarily US-focused impact via a NASDAQ-listed issuer; no cross-market spillover details in the article.
Limited global relevance since the disclosure is company-specific and not tied to international policy or supply shocks.
Counterpoint
The article reconfirms guidance but does not show any upward revision, so the initial pop could fade if investors expected a raise.
Key entities
- companySotera Health Company
NASDAQ-listed healthcare services company reporting Q3 2026 results and reconfirming full-year guidance.



